Lexaria Bioscience Corp Cash Flow Reinvestment Rate

Latest as of November 2013: 0.37x

Lexaria Bioscience Corp cash flow reinvestment rate. Lexaria Bioscience Corp (LEXX) has a Cash Flow Reinvestment Rate of 0.37x as of November 2013, reinvesting $27.23K (capex $27.23K ) from operating cash flow of $74.27K. Explore Lexaria Bioscience Corp debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.37x
(Capex + Investments) / Operating CF

Total Reinvested

$27.23K
Capex + Investments

Operating Cash Flow

$74.27K
USD

Capital Expenditures

$27.23K
USD

Cash Flow Reinvestment Rate of Lexaria Bioscience Corp (2007–2014)

Cash flow reinvestment rate of Lexaria Bioscience Corp from 2007 to 2014. Historical reinvestment intensity for Lexaria Bioscience Corp across 6 annual periods. Explore Lexaria Bioscience Corp capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Lexaria Bioscience Corp Cash Flow Reinvestment Rate by Year (2007–2014)

Lexaria Bioscience Corp cash flow reinvestment rate by year from 2007 to 2014. Year-by-year capital reinvestment analysis for Lexaria Bioscience Corp. For the full cash flow conversion analysis, see LEXX operating cash flow.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2014 0.29x $91.61K $321.00K $91.61K ▲ +0.0%
2013 0.29x $91.61K $321.00K $91.61K ▲ +0.0%
2012 0.29x $91.61K $321.00K $91.61K ▼ -85.8%
2011 2.02x $274.13K $135.94K $274.13K ▼ -77.9%
2010 9.13x $1.00 Million $109.84K $1.00 Million ▼ -54.5%
2007 20.06x $582.43K $29.04K $582.43K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow